medigraphic.com
ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC

2018, Number 2

<< Back Next >>

An Med Asoc Med Hosp ABC 2018; 63 (2)

Severe malaria due to Plasmodium falciparum

Cuenca AD, Gómez JVH, Romo LA, Valente-Acosta B

Language: Spanish
References: 13
Page: 134-137
PDF size: 194.47 Kb.


ABSTRACT

Malaria is the most important parasitic disease worldwide. The main area at risk is sub-Saharan Africa, where 85% of the cases occurred and 90% of deaths due to malaria. In Mexico, the risk entities are Chiapas, Oaxaca, Quintana Roo, Tabasco, Chihuahua, Durango, Jalisco, Nayarit, Sinaloa and Sonora. However, Latin America holds only 1% of all diagnosis. The objective is describing a case of imported severe malaria due to Plasmodium falciparum. We present a clinical case of a 34-year-old man who was admitted with fever and thrombocytopenia, as a three-month history in Angola; prophylaxis with mefloquine with poor adherence. Severe malaria is diagnosed by Plasmodium falciparum. The importance of this case lies mainly in two situations: the patient lived in a country considered endemic to malaria (Mexico), where reported cases are mainly due to Plasmodium vivax, but he travelled to the area with the highest burden of disease: Sub-Saharan Africa, where Plasmodium falciparum predominates.


REFERENCES

  1. Cowman AF, Healer J, Marapana D, Marsh K. Malaria: biology and disease. Cell. 2016; 167 (3): 610-624.

  2. WHO. World malaria report 2015. [Consulted 12 December 17] Available in: apps.who.int/iris/bitstream/10665/200018/1/9789241565158_eng.pdf.

  3. Daily JP. Malaria 2017: update on the clinical literature and management. Curr Infect Dis Rep. 2017; 19 (8): 28.

  4. Phillips MA, Burrows JN, Manyando C, van Huijsduijnen RH, Van Voorhis WC, Wells TNC. Malaria. Nat Rev Dis Primers. 2017; 3 (17050).

  5. Centers for Disease Control and Prevention. Malaria Information and Prophylaxis by Country. [Consulted 12 December 17] Available in: https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/malaria

  6. Velázquez GA, Álvarez MF, Zavala GC. Paludismo. Reporte de un caso y revisión de la literatura. Med Sur. 2006; 13 (3): 129-135.

  7. Kaneko WFT, Muñoz MOE, Hernández DS, Guevara OA, Salgado CJ, Pescina CJ. Paludismo grave por Plasmodium vivax: reporte de un caso y revisión de la bibliografía. Med Int Mex. 2009; 25 (3): 233-240.

  8. White NJ, Pukrittayakamee S, Hien TT, Faiz MA, Mokuolu OA, Dondorp AM. Malaria. Lancet. 2014; 383 (9918): 723-735.

  9. Wilairatana P, Tangpukdee N, Krudsood S. Definition of hyperparasitemia in severe falciparum malaria should be updated. Asian Pac J Trop Biomed. 2013; 3 (7): 586.

  10. Lo E, Nguyen K, Nguyen J, Hemming-Schroeder E, Xu J, Etemesi H et al. Plasmodium malariae prevalence and csp gene diversity, Kenya, 2014 and 2015. Emer Infec Dis. 2017; 23 (4): 601-609.

  11. Patel D, Pradeep P, Surti MM, Agarwal SB. Clinical manifestations of complicated malaria, an overview. JIACM. 2003; 4 (4): 323-331.

  12. Jaroonvesama N. Intravascular coagulation in falciparum malaria. Lancet. 1972; 299 (7744): 221-223.

  13. Organización Mundial de la Salud. Tratamiento del Paludismo Grave. Manual Práctico, 3a. ed. 2013, pp. 26-38.




2020     |     www.medigraphic.com